Knowledge Center

Membership Resources


Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.

After making your filter selections, please scroll down to see results.

Filters
Clear All
Results 358
Articles

Nonalcoholic Fatty Liver Disease: The Hepatic Complication of Metabolic Dysmetabolism

Nonalcoholic fatty liver disease (NAFLD) is the main hepatic complication of obesity, diabetes and metabolic syndrome.  Its prevalence has risen dramatically since 1980, when it was a perplexing and sporadically-observed disease as first reported by…

Read More |
Articles

National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk

The 2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the Management of Blood Cholesterol reaffirmed that lifestyle changes and statin treatment are therapeutic cornerstones…

Read More |
Articles

A Personalized Approach to Risk Stratification

Clinical practice guidelines are integral to daily management of cardiovascular diseases, including hyperlipidemia. The most 2018 Multisociety Cholesterol Guidelines advocate for a more personalized approach…

Read More |
Articles

Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force

This scientific statement provides a comprehensive review of the current evidence base available from recent systematic reviews and meta-analyses on the effects of low-CHO and…

Read More |
Infographics

Effects of Low-Carbohydrate and Very-Low-Carbohydrate Diets (Including Ketogenic) – Cardiometabolic Impact

Read More |
Infographics

Enhancing the Value of PCSK9 Monoclonal Antibodies (MAb)

Read More |
Articles

Statin Use in Chronic Hepatitis C Infection, NAFLD/NASH, Cirrhosis and Hepatocellular Carcinoma

Case Presentation: G.S. is a 60-year-old male referred for cholesterol treatment complicated by background liver disease. He has a history of schizophrenia and chronic hepatitis C virus (HCV) diagnosed in 2016. He is asymptomatic and…

Read More |
Articles

Getting the e-Patient Equipped and Engaged

Patients often search the internet for medical answers and solutions before talking to their healthcare provider (HCP). This article provides practice pearls for conversing with…

Read More |